Literature DB >> 25133601

Dried platelets in a swine model of liver injury.

Kenji Inaba1, Galinos Barmparas, Peter Rhee, Bernardino C Branco, Michael Fitzpatrick, Obi T Okoye, Demetrios Demetriades.   

Abstract

INTRODUCTION: Lyophilization may facilitate production of a safe, portable, easily storable, and transportable source of platelets for bleeding patients. The objective of this study was to examine the impact of lyophilized human and porcine platelets in a swine liver injury model of nonsurgical hemorrhage.
METHODS: Anesthetized pigs (40 kg) had a controlled 35% total blood volume bleed from the right jugular vein followed by cooling to 35°C and resuscitation with Ringer's lactate to achieve a 3:1 blood withdrawal resuscitation. Through a midline laparotomy, the liver was injured with two standardized 5 × 5-cm grids with lacerations 1 cm apart and 0.5 cm deep. After 2 min of uncontrolled hemorrhage, the animals were treated with placebo (n = 5), lyophilized human (n = 5, HP), or swine platelets (n = 5, SP). At 15 min, shed blood was calculated. The animals then underwent abdominal closure. At 48 h, the animals were killed for histopathologic evaluation of the lung, kidney, and heart.
RESULTS: Intraoperative blood loss at 15 min was significantly higher in the HP arm (SP: 4.9 ± 2.9 mL/kg, HP: 12.3 ± 4.7 mL/kg, and control: 6.1 ± 2.5 mL/kg; P = 0.013). Mortality at 48 h was 20% in all three arms, due to uncontrolled intra-abdominal bleeding. At the time the animals were killed, SP animals had a significantly higher hematocrit (SP: 22.0% ± 3.0%, HP: 15.1% ± 4.9%, and control: 13.9% ± 0.6%; P = 0.026). No significant difference was found in platelet count (SP: 319.3 ± 62.1 × 10(3)/µL, HP:361.5 ± 133.6 × 10(3)/µL, and control: 242.7 ± 42.5 × 10(3)/µL; P = 0.259). Histopathology of kidneys, lungs, and heart demonstrated no evidence of thromboembolic complications.
CONCLUSION: In this swine model of liver injury, human lyophilized platelets increased intraoperative blood loss. With the use of species-specific lyophilized platelets, however, this effect was abolished, with a decrease in blood loss at 48 h after injury.

Entities:  

Mesh:

Year:  2014        PMID: 25133601     DOI: 10.1097/SHK.0000000000000141

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  5 in total

Review 1.  The Chemistry of Lyophilized Blood Products.

Authors:  Joseph Fernandez-Moure; Nuzhat Maisha; Erin B Lavik; Jeremy W Cannon
Journal:  Bioconjug Chem       Date:  2018-06-13       Impact factor: 4.774

2.  Comparison of Neonatal and Adult Fibrin Clot Properties between Porcine and Human Plasma.

Authors:  Kimberly A Nellenbach; Seema Nandi; Alexander Kyu; Supriya Sivadanam; Nina A Guzzetta; Ashley C Brown
Journal:  Anesthesiology       Date:  2020-05       Impact factor: 7.892

Review 3.  There and back again: the once and current developments in donor-derived platelet products for hemostatic therapy.

Authors:  Valery J Kogler; Moritz Stolla
Journal:  Blood       Date:  2022-06-30       Impact factor: 25.476

Review 4.  Platelet Transfusion-Insights from Current Practice to Future Development.

Authors:  Annina Capraru; Katarzyna Aleksandra Jalowiec; Cesare Medri; Michael Daskalakis; Sacha Sergio Zeerleder; Behrouz Mansouri Taleghani
Journal:  J Clin Med       Date:  2021-05-06       Impact factor: 4.241

Review 5.  Hemostatic agents for prehospital hemorrhage control: a narrative review.

Authors:  Henry T Peng
Journal:  Mil Med Res       Date:  2020-03-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.